Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222241 · ClinicalTrials.gov registry record · NA
Comparing Numbing Techniques in Mohs Micrographic Surgery
A NA study of Skin Cancer Face and Skin Cancer Scalp, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07222241 is a NA study of Skin Cancer Face and Skin Cancer Scalp that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07222241, a NA study of Skin Cancer Face and Skin Cancer Scalp, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to determine whether adjunct regional nerve blocks reduce pain and anxiety in adult patients undergoing Mohs micrographic surgery for face and scalp skin cancers. Participants will be randomized to one of two arms: (1) placebo regional nerve block with sterile normal saline or (2) adjunct regional nerve block with lidocaine. All patients receive local infiltration with lidocaine for complete anesthesia.
Conditions Studied
Interventions
- OTHER Nerve Block
- OTHER Placebo Nerve Block
Study Locations (1)
Pennsylvania
- Perelman Center for Advanced Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-01-27 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07222241
The ClinicalTrials.gov registry entry for NCT07222241 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Skin Cancer Face appearing as the primary indexed condition, and to 2 interventions - of which Nerve Block is the first listed.
NCT07222241 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07222241 about?
NCT07222241 is a clinical study titled "Comparing Numbing Techniques in Mohs Micrographic Surgery". This study seeks to determine whether adjunct regional nerve blocks reduce pain and anxiety in adult patients undergoing Mohs micrographic surgery for face and scalp skin cancers. Participants will be randomized to one of two arms: (1) placebo regional nerve block with sterile normal saline or (2) a...
What is the current status of trial NCT07222241?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-01-27. Estimated completion is 2026-07-31.
What conditions does trial NCT07222241 study?
This clinical trial studies the following conditions: Skin Cancer Face, Skin Cancer Scalp.
What interventions are being tested in trial NCT07222241?
The interventions under investigation include: Nerve Block (OTHER), Placebo Nerve Block (OTHER).
Who is sponsoring clinical trial NCT07222241?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222241 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer Face
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.